NewStem vs Spade Therapeutics
NewStem vs Spade Therapeutics, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: NewStem is on 45/100 and Spade Therapeutics on 38/100.
Where each one leads
NewStem
- our overall score: 45/100 against 38/100
- agent readiness: 50/100 against 22/100
Spade Therapeutics
- funding raised: $40.0M against $30.0M
At a glance
| Measure | NewStem | Spade Therapeutics |
|---|---|---|
| What it is | Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy. | Drug discovery and development company using a novel technological approach. |
| Category | Life Sciences, Biotech, Biopharmaceutical, MedTech | Life Sciences, Drug Discovery, Drug Development, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2018 | 2022 |
| Headquarters | Rehovot, Israel | Cambridge, United States |
| Status | Active | Inactive |
Size, funding and growth
| Measure | NewStem | Spade Therapeutics |
|---|---|---|
| Total funding | $30.0M | $40.0M |
| Latest round | Series B | Series B |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | NewStem | Spade Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 45/100 | 38/100 |
| Traction | 37/100 | 38/100 |
| Team | 30/100 | 30/100 |
| Community | Not published | 15/100 |
| Search visibility | 9/100 | 2/100 |
| Quality | 58/100 | 45/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (50/100) | F (22/100) |
| Domain ratingLink authority, 0-100 | 4/100 | Not published |
NewStem vs Spade Therapeutics: common questions
Which is better, NewStem or Spade Therapeutics?
On our 0-100 score NewStem rates higher (45/100 against 38/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do NewStem and Spade Therapeutics compare on the numbers?
NewStem leads on our overall score (45/100 against 38/100), agent readiness (50/100 against 22/100). Spade Therapeutics leads on funding raised ($40.0M against $30.0M).
Read the full NewStem review and pricing or the Spade Therapeutics review and pricing. You can also browse other NewStem alternatives we track.